(AGENPARL) - Roma, 3 Ottobre 2024 - (AGENPARL) – gio 03 ottobre 2024 Lund, Sweden, October 3, 2024. Hansa Biopharma, “Hansa” (Nasdaq Stockholm:
HNSA), will publish its interim report for January-September 2024 on October 17,
2024. Interested parties may join the Company’s quarterly conference call on the
same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren Tulstrup,
President and CEO, Evan Ballantyne, CFO, and Hitto Kaufmann, CR&DO. The call
will include a review of the interim results and a business and pipeline update.
It will be held in English.
Slides used in the presentation will be made available on the company website at
the following link: Financial
reports (https://www.hansabiopharma.com/investors/financial-reports/).
To participate in the telephone conference, please use the dial-in details
provided below:
Participant Toll Free Dial-in: 1-877-270-2148
International Dial-in: 1-412-902-6510
The webcast will be available on
https://event.choruscall.com/mediaframe/webcast.html?webcastid=ld2DsRXz
— ENDS —
Contacts for more information:
Evan Ballantyne, Chief Financial Officer
Stephanie Kenney, VP Global Corporate Affairs
About Hansa Biopharma
Hansa Biopharma is a pioneering commercial-stage biopharmaceutical company on a
mission to develop and commercialize innovative, lifesaving and life-altering
treatments for patients with rare immunological conditions. Hansa Biopharma has
developed a first-in-class immunoglobulin G (IgG) antibody-cleaving enzyme
therapy, which has been shown to enable kidney transplantation in highly
sensitized patients. Hansa Biopharma has a rich and expanding research and
development program based on the Company’s proprietary IgG-cleaving enzyme
technology platform, to address serious unmet medical needs in transplantation,
autoimmune diseases, gene therapy and cancer. Hansa Biopharma is based in Lund,
Sweden, and has operations in Europe and the U.S. The company is listed on
Nasdaq Stockholm under the ticker HNSA. Find out more at www.hansabiopharma.com
and follow us on LinkedIn (https://www.linkedin.com/company/hansa-medical-ab/).
©2024 Hansa Biopharma AB. Hansa Biopharma, the beacon logo, IDEFIRIX, and
IDEFIRIX flower logo are trademarks of Hansa Biopharma AB, Lund, Sweden. All
rights reserved.
If you would rather not receive future communications from Hansa Biopharma AB, please go to https://optout.ne.cision.com/en/2X67QqbNSj16Mcdut1NVctMUnTTxx2djUMjjdj1HnjEv5T9LVer5kroL2CsD6eapmdpxrbXLr5wrLN25rAwAPmW2X3hPoS33uhT5Zvxgz4wtVo.
Hansa Biopharma AB, Scheelevägen 22, Lund, 22362 Sweden
————————————————————
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
If you would rather not receive future communications from Hansa Biopharma AB, please go to https://optout.ne.cision.com/en/2X67QqbNSj16Mcdut1NVctMUnTTxx2djUMjjdj1HnjEv5T9LVer5kroL2CsD6eapmdpxrbXLr5wrLN25rAwAPmW2X3hPoS33uhT5Zvxgz4wtVo.
Hansa Biopharma AB, Scheelevägen 22, Lund, 22362 Sweden
Report this content
Trending
- Dl Cortei, Pastorella (Az): “Governo arriva tardi sulla protezione dei minori online”
- Islam prima religione al mondo entro il 2035: lo studio del Pew Research Center prevede il sorpasso sui cristiani
- IMAM DI REGGIO EMILIA, CISINT (LEGA): “FUORI I PREDICATORI D’ODIO CONTRO L’OCCIDENTE
- Funzioni Locali: l’allarme sui divari territoriali e la sfida dell’innovazione, CSE e FLP lanciano la proposta di un “Patto per le Funzioni Locali”
- Nuova campagna di phishing per rubare i dati degli utenti. Online un falso sito dell’Agenzia delle entrate: ecco come difendersi
- RAI, M5S: SOLIDARIETA A GIORNALISTA SPOTLIGHT, VERTICI RITIRINO RICHIAMO A SCANDALIATO
- Paroli (FI), bene fermata Tav Basso Garda, ora avanti su Ponte Stretto
- AGRICOLTURA, RUSSO (FdI): “INCHIESTA SU BLOCCHI TRATTORI SVELA UNA VICENDA BEN DIVERSA DA QUELLA NARRATA DALLA SINISTRA. A PAGARNE IL PREZZO I CONSUMATORI”
- Genitori separati: Potenti (Lega), aiuto concreto sugli affitti, sostegno reale per chi ricomincia
- DECRETO SCUOLA. DE CARLO (FdI): GRAZIE AD EMENDAMENTO SOTTOSCRITTO CON BUCALO PIÙ TUTELA PER GLI ISTITUTI TECNICI E PROFESSIONALI LEGATI ALLE VOCAZIONI PRODUTTIVE DEI TERRITORI